And sphs is now only valued at 1% of mdvn's value. SPHS Should/could be trading at 20-40% of mdvn value or $40-80/share. One less cancer cure bio available for purchase and here sits SPHS listening to bp buyout offers that continue to get pricier. Fair market value is still $20-40 right now with only 20 million shares outstanding and only 5-6 million not locked up by institutions and longs.